Article
Development of serum-free medium supplemented with hydrolysates for the production of therapeutic antibodies in CHO cell cultures using design of experiments.
Department of Biological Sciences, KAIST, Daejeon, South Korea.
Applied Microbiology and Biotechnology (impact factor:
3.42).
04/2009;
83(4):639-48.
DOI:10.1007/s00253-009-1903-1
pp.639-48
Source: PubMed
-
Citations (0)
- Cited In (1)
-
Article: Chromatographic fractionation of yeast extract: A strategy to identify physicochemical properties of compounds promoting CHO cell culture
[show abstract] [hide abstract]
ABSTRACT: The study proposes to get a better knowledge of the physicochemical properties of yeast extract (YE) molecules involved in the improvement of CHO cell growth and to reduce YE complexity without losing positive effects. Various chromatographic processes were implemented for fractionation of a nanofil-trated YE (nYE). The nYE was first fractionated by one-step preparative chromatography, either with anion exchange (AEC), hydrophobic interaction (HIC) or size exclusion (SEC) methods. After analysis of its main components, each fraction was added in a control chemically defined medium to assess its impact on CHO cell growth. Results mainly underlined that AEC was the most selective separation process to purify nYE in one step without decreasing cell growth promoting effect. A three-step chromatographic process including successive AEC, HIC, and SEC was then developed to refine the physicochemical prop-erties of nYE compounds. Among fractions that triggered similar cell growth promoting effect than nYE, one also improved IgG specific production. It mainly included cationic and hydrophilic peptides with a great proportion of lysine and arginine, low quantities of polysaccharides and no nucleic acids. Thus, this study allowed us to deepen the YE contribution to animal cell culture as well as to evaluate fractionation strategies to simplify such a complex mixture.Process Biochemistry 01/2012; 47:1178-1185. · 2.44 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
basal SFM
cell growth
efficient method
formulating serum-free medium
maximum antibody concentration
mixtures
positive effect
rCHO cell lines
rCHO cells
recombinant CHO
resulting medium
soy hydrolysate
specific antibody productivity
statistical program Design-Expert(R)
therapeutic antibodies
therapeutic antibody
therapeutic antibody production
three hydrolysates
two rCHO cell lines
wheat gluten hydrolysate